WINNIPEG — The province will cover 153 new drugs through Pharmacare beginning on Monday.
They include many generic brands that are expected to save Manitoba Health an estimated $2.9 million per year.
The new drugs include treatments for diabetes, hypertension, heart disease, colitis and Crohn’s disease.
Specific drugs include Brilinta for reducing the risk of heart attack, Mezavant for treatment of ulcerative colitis and Crohn’s disease, and Protopic for the treatment of moderate to severe eczema.
According to the Canadian Generic Pharmaceutical Association, generic drugs accounted for 65.1 per cent of prescriptions in Manitoba in 2011 — the highest use of generics in Canada.
Pharmacare is a universal, comprehensive prescription drug program. It covers 100 per cent of Manitobans’ eligible drug costs once an income-based deductible is reached.
» Winnipeg Free Press
Republished from the Brandon Sun print edition January 19, 2013
Sort by: Newest to Oldest | Oldest to Newest | Most Popular 0 Comments
You can comment on most stories on brandonsun.com. You can also agree or disagree with other comments. All you need to do is register and/or login and you can join the conversation and give your feedback.